9th CKD (Chronic Kidney Disease Drug Development) Summit

The 9th CKD (Chronic Kidney Disease Drug Development) Summit focuses on the latest advancements in chronic kidney disease drug development, addressing glomerular diseases, innovative trial designs, and emerging therapeutic approaches for CKD.

Key Topics

• Innovative Approaches to CKD Trial Design: Bridging Confidence, Superiority, & Patient Perspectives
• Exploring the Next Frontier in CKD: Future Directions & Emerging Therapeutic Innovations in CKD Beyond SGLT2’s
• Redefining Kidney Disease Care: From Breakthrough Discoveries to Next-Gen Clinical Trials
• Examining the Intricacies of Glomerular Disease Drug Development to Uncover Innovative Approaches to Treatment
• Future Directions for Glomerular Diseases
• From IgA Nephropathy to Broader Glomerular Diseases: Learning from Success to Shape the Future
• Innovating Beyond the Generics: Innovative Approaches to Treating Glomerular Diseases & New Pathways for Intervention
• Adapting to the Changing Renal Landscape & Implications on Drug Discovery & Development
• Navigating the Evolving Landscape of Kidney Health: Insights into CKM, GLP-1 Mechanisms, & Treatment Combinations
• Moving Beyond Precision Medicine to Stratified Medicine: Getting the Right Drug to the Right Patient at the Right Time to Improve Therapeutic Benefit

Who should Attend

• Researchers and scientists in nephrology and kidney health
• Pharmaceutical professionals and drug developers
• Healthcare providers and clinicians specializing in renal care
• Biotech companies focused on chronic kidney disease
• Clinical trial designers and coordinators
• Regulatory professionals in the kidney health field
• Pharmacologists and medical professionals interested in CKD treatments